More on CELG

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+28.5% Growth)
- Ratings (7.6 Score)
- Holders
- Event Driven Deals

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (1/27/17 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

CELG Income Statement

Click line-items for a historical chart and %
Revenue:
Net product sales 2.97B
Collaborative agreements and other revenue 14.2M
Royalty revenue
Total revenue 2.98B
Expenses:
Cost of goods sold (excluding amortization of acquired intangible assets)
Research and development 1.65B
Selling, general and administrative 698M
Amortization of acquired intangible assets
Acquisition related (gains) charges and restructuring, net 25M
Total costs and expenses 2.57B
Operating income 411.5M
Other income and expense:
Interest and investment income, net 7.3M
Equity in (gains) losses of affiliated companies
Interest expense -127.8M
Other income, net -34.2M
Income before income taxes 256.8M
Income tax provision 85.4M
Net income 171.4M
Less: Net loss attributable to non-controlling interest
Net income attributable to Celgene
Net income per share attributable to Celgene:
Basic 0.22
Diluted 0.21
Weighted average shares:
Basic 775.8M
Diluted 801.5M